{"id":7,"date":"2024-04-04T03:43:28","date_gmt":"2024-04-04T00:43:28","guid":{"rendered":"https:\/\/sisu.ut.ee\/hiv\/ettekanded\/"},"modified":"2024-04-12T14:09:00","modified_gmt":"2024-04-12T11:09:00","slug":"ettekanded","status":"publish","type":"page","link":"https:\/\/sisu.ut.ee\/hiv\/ettekanded\/","title":{"rendered":"Ettekanded"},"content":{"rendered":"

2017<\/strong><\/span><\/p>\n

Avi, R; Pauskar, M; Rajasaar, H; Kallas, E; J\u00f5geda, E; Soodla, P; Lutsar, I;\u00a0 Huik, K;\u00a0Virologic responce to antiretroviral treatment in an Eastern European cohort study\u00a0\u00a0USA, Seattle, veebr\u00a02017\u00a0(posterettekanne)<\/span><\/p>\n

Huik, K; Soodla,P; Pauskar, M; Rajasaar, H; J\u00f5geda, E; Kallas, E; Avi, R; Lutsar, I.\u00a0The evaluation of two HIV-1 incidence assays in subjecys infected with non-B subtype viruses\u00a0Austria, Viin, aprill 2017 (posterettekanne)<\/span><\/p>\n

\n

<\/span><\/p>\n

2015<\/strong><\/span><\/p>\n

Kallas, E.; Avi, R.; Huik, K.; T\u00fcrk, S.; Pauskar, M.; J\u00f5geda, E.-.L.; \u0160unina, M.; Des Jarlais, D.; Uusk\u00fcla, A.; Lutsar, I. (2015).\u00a0The distribution of TEMRA cells is influenced by HIV, HBV, HCV infections and intravenous drug use.<\/em><\/strong>\u00a025th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.<\/em><\/span><\/p>\n

Pauskar, M; Avi, R.; Kallas, E.; J\u00f5geda, E-L.; Karki, T.; Uusk\u00fcla, A.;\u00a0\u00a0Des Jarlais, D; Lutsar, I.; Huik, K.\u00a0Association between IL28B rs12979860 genotypes and susceptibility to HCV and\/or HIV infection in Caucasian intravenous drug users.<\/em><\/strong>\u00a025th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.<\/em><\/span><\/p>\n

Kase, K.; Rajasaar, H.; Avi, R.; Pauskar, M.; Zilmer, K.; Kink, K.; Novikova, L.;\u00a0\u00a0Maimets, M.; Lutsar, I.; Huik, K.\u00a0Co-infection with hepatitis C virus in Estonian HIV population during last two decades.\u00a0<\/em><\/strong>25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.<\/em><\/span><\/p>\n

Soodla, P.; Rajasaar, H.; Maimets, M.; Lutsar, I.\u00a0The Estonian HIV Cohort Study: Participant Characteristics Over Time<\/em><\/strong>.<\/em><\/strong>\u00a025th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.<\/em><\/span><\/p>\n

\n

2014<\/strong><\/span><\/p>\n

Avi, R.; Huik, K.; Pauskar, M.; Kallas, E.; J\u00f5geda, E.-L.; Zilmer, K.; Ustina, V.; Novikova, L.; Karki, T.; Kisand, V.; Lutsar, I. (2014).\u00a0Full-Length Genome Sequences of Estonian HIV-1 CRF06 and Eastern-European Subtype A1 Recombinant Forms.<\/em><\/strong>\u00a07th National Congress HIV\/AIDS and the 2nd Central European HIV Forum, Sibiu, Romania, 29-31 May 2014.<\/em><\/span><\/p>\n

J\u00f5geda, E.-L.; Huik, K.; Avi, R; Pauskar, M., Kallas, E.; Karki, T.; Marsh, K.; Des Jarlais, D.; Uusk\u00fcla, A.; Lutsar, I. (2014).\u00a0Associations between MX2 polymorphism and the acquisition of HIV and co-infections in Caucasian intravenous drug users (IDUs).<\/em><\/strong>\u00a0European Human Genetics Conference 2014, Milan, Italy, 31 May-3 June 2014.<\/em><\/span><\/p>\n

Kallas, E.; Avi, R.; Huik, K.; T\u00fcrk, S.; Pauskar, M.; J\u00f5geda, E.-.L.; \u0160unina, M.; Des Jarlais, D.; Uusk\u00fcla, A.; Lutsar, I. (2014).\u00a0Injection drug use influences T-cell distribution and CCR5 expression in HIV+ and ESN population.<\/em><\/strong>\u00a024th European Congress of Clinical Microbiology and Infectious Diseases; Barcelona; 10-13 May 2014.<\/em><\/span><\/p>\n

Kallas, E.; Huik, K.; Avi, R; Pauskar, M.; J\u00f5geda, E.-L.; Karki, T.; Marsh, K.; Des Jarlais, D.; Uusk\u00fcla, A.; Lutsar, I. (2014).\u00a0NLRP3 genotype CG increases the risk of HIV-1 in Caucasian intravenous drug users (IDUs).<\/em><\/strong>\u00a0European Human Genetics Conference 2014, Milan, Italy, 31 May-3 June 2014.<\/em><\/span><\/p>\n

Pauskar, M.; Huik, K.; Avi, R.; Kallas, E.; J\u00f5geda, E.-L.; Karki, T.; Semjonova, S.; Smidt, J.; Novikova, L.; Ainsalu, K.; Lutsar, I. (2014).\u00a0Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy.<\/em><\/strong>\u00a07th National Congress HIV\/AIDS and the 2nd Central European HIV Forum, Sibiu, Romania, 29-31 May 2014.<\/em><\/span><\/p>\n

\n

2013<\/strong><\/span><\/p>\n

Avi, R; Huik, K; Pauskar, M; Kallas, E; J\u00f5geda, EL; Karki, T; \u0160midt, J; Novikova, L; Semjonova, S; Lutsar, I. (2013).\u00a0Substitutions in RNaseH and Connection domain of HIV-1 CRF06_cpx viruses in treatment naive and treatment experienced populations.<\/em><\/strong>\u00a011th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013, 35 \u2013 35.<\/em><\/span><\/p>\n

J\u00f5geda, EL; Huik, K; Pauskar, M; Kallas, E; Krispin, T; Karki, T; Marsh, K; Des Jarlais, D; Uusk\u00fcla, A; Avi, R; Lutsar, I. (2013).\u00a0The prevalence of GBV-C and its associations with HIV infection among Estonian intravenous drug users.<\/em><\/strong>\u00a0In: Reviews in Antiviral Therapy Infectious Diseases: 11th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013, 46 \u2013 47.<\/em><\/span><\/p>\n

Kallas, E; Huik, K; Avi, R; Pauskar, M; J\u00f5geda, EL; Karki, T; Marsh, K; Des Jarlais, D; Uusk\u00fcla, A; Lutsar, I (2013).\u00a0The IL-10 promoter genotype AA at -592 is correlated with increased susceptibility to hepatitis B but not HIV infection in Caucasian intravenous drug users.<\/em><\/strong>\u00a0European Human Genetics Conference 2013, Paris, France, 8.06.13-11.06.13.<\/em><\/span><\/p>\n

\n

2012<\/strong><\/span><\/p>\n

Avi, R.; Huik, K.; Pauskar, M., Lutsar, I.; Vandamme, A.; Abecasis, A. (2012).\u00a0The population dynamics of the HIV-1 epidemic in Estonia through virus genetic analysis and national case recording.<\/em><\/strong>\u00a017th International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology, 27-31 August 2012 Belgrade Serbia.<\/em><\/span><\/p>\n

Avi, R.; Huik, K.; Pauskar, M.; Kallas, E.; Karki, T.; Krispin, T.; Ainsalu, K.; Semjonova, S.; Kool, P.; Novikova, L.; Schmidt, J.; Lutsar, I. (2012).\u00a0The pattern of drug resistance mutations in HIV-1 CRF06_cpx viruses failing the first-line NNRTI+2NRTI antiretroviral therapy.<\/em><\/strong>\u00a010th European Meeting on HIV & Hepatitis \u2013 Treatment Strategies & Antiviral Drug Resistance, 28 \u2013 30 March 2012 Barcelona Spain.<\/em><\/span><\/p>\n

Kallas, E.; Avi, R.; Huik, K.; Pauskar, M.; Ustina, V.; Karki, T.; Krispin, T.; Ainsalu, K.; Semjonova, S.; Kool, P.; Novikova, L.; Schmidt, J.; Lutsar, I. (2012).\u00a0HIV Type-1 CRF06_cpx P(T\/S)AP Late Domain duplications are outselected among treatment experienced compared to treatment na\u00efve patients.<\/em><\/strong>\u00a0Reviews in Antiviral Therapy & Infectious Diseases.<\/em><\/span><\/p>\n

Pauskar, M.; Avi, R.; Huik, K.; Ustina, V.; J\u00f5geda, E.; Kallas, E.; Karki, T.; Krispin, T.; Lutsar, I. (2012).\u00a0Transmitted drug resistance is 4.5% in newly diagnosed mainly HIV-1 CRF06_cpx infected patients in Estonia in 2010.<\/em><\/strong>\u00a010th European Meeting on HIV & Hepatitis \u2013 Treatment Strategies & Antiviral Drug Resistance, 28 \u2013 30 March 2012 Barcelona Spain.<\/em><\/span><\/p>\n

Uibopuu, H.; Huik, K.; Avi, R.; Pauskar, M.; Kallas, E.; Karki, T.; Krispin, T.; Kool, P.; Schmidt, J.; R\u00fc\u00fctel, K.; Talu, A.; Abel-Ollo, K.; Uusk\u00fcla, A.; Lutsar, I. (2012).\u00a0Viral tropism of HIV-1 CRF06_cpx and its association with CCR5 haplotypes.<\/em><\/strong>\u00a010th European Meeting on HIV & Hepatitis \u2013 Treatment Strategies & Antiviral Drug Resistance, 28 \u2013 30 March 2012 Barcelona Spain.<\/em><\/span><\/p>\n

\n

2009<\/strong><\/span><\/p>\n

Huik, K.; Avi, R.; Sadam, M.; Karki, T.; Denks, K.; Krispin, T.; Ustina, V.; R\u00fc\u00fctel, K.; Uusk\u00fcla, A.; Murphy, G.; Lutsar, I. (2009).\u00a0Performance of the BED-CEIA in population infected with HIV1 recombinant viruses CRF06cpx and CRF06A.<\/em><\/strong>\u00a0In: Clinical Microbiology and Infection: 19th European Congress of Clinical Microbiology and Infectious Diseases Helsinki, Finland, 16 \u2013 19 May 2009.<\/em><\/span><\/p>\n

\n

2008<\/strong><\/span><\/p>\n

Avi, R.; Huik, K.; Karki, T.; Sadam, M.; Krispin, T.; Ainsalu, K.; Paap, P.; Schmidt, J.; Nikitina, N.; Lutsar, I. (2008).\u00a0Drug Resistance Mutations and Genetic Barrier for Drug Resistance Development in Estonian HIV-1 CRF06_cpx Integrase Sequences.<\/em><\/strong>\u00a014th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology; Cape Town, South Africa; 1-5 September 2008.<\/em><\/span><\/p>\n

Avi, R.; Huik, K.; Sadam, M.; Karki, T.; Krispin, T.; Paap, P.; Ainsalu, K.; Schmidt, J.; Nikitina, N.; Lutsar, I. (2008).\u00a0Natural polymorphisms associated with integrase inhibitor drug resistance in Estonian HIV-1 CRF06_cpx strains.<\/em><\/strong>\u00a018th European Congress of Clinical Microbiology and Infectious Diseases; Barcelona; 19.04-22.04.2008.<\/em><\/span><\/p>\n

Huik, K.; Avi, R.; Sadam, M.; Karki, T.; Albert, J.; Lutsar, I. (2008).\u00a0Drug Resistance Mutations in HIV-1 CRF06_cpx Viruses Isolated from Treatment Na\u00efve and Experienced Patients.<\/em><\/strong>\u00a0In: European Journal of Medical Research: 19th European Students\u2019 Conference; Berlin; 28 September \u2013 3 October 2008.<\/em><\/span><\/p>\n

Sadam, M.; Karki, T.; Huik, K.; Avi, R.; R\u00fc\u00fctel, K.; Uusk\u00fcla, A.; Lutsar, I (2008).\u00a0CCL3L1 Variable Gene Copy Number Influence on the Susceptibility to HIV-1\/AIDS Among Estonian Intravenous Drug User.<\/em><\/strong>\u00a0The 15th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, 03.02-06.02.2008.<\/em><\/span><\/p>\n

\n

2007<\/strong><\/span><\/p>\n

Avi, R.; Huik, K.; Karki, T.; Sadam, M.; Paap, P.; Smidt, J.; Ainsalu, K.; Krispin, T.; Lutsar, I (2007).\u00a0The coexistence of secondary PR mutations M36I, K20I and L63H predominates in CRF06_cpx and its next generation recombinant virusese circulating in Estonian treatment naive patients.<\/em><\/strong>\u00a0In: International Journal of Antimicrobial Agents, S549 \u2013 S549.<\/em><\/span><\/p>\n

Denks, K.; Huik, K.; Avi, R.; Sadam, M.; Krispin, T.; Lutsar, I. (2007).\u00a0GB virus C infection among HIV-positive patients in Estonia.<\/em><\/strong>\u00a0International Journal of Antimicrobial Agents, 29(3), S155 \u2013 S155.<\/em><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

2017 Avi, R; Pauskar, M; Rajasaar, H; Kallas, E; J\u00f5geda, E; Soodla, P; Lutsar, I;\u00a0 Huik, K;\u00a0Virologic responce to antiretroviral treatment in an Eastern European cohort study\u00a0\u00a0USA, Seattle, veebr\u00a02017\u00a0(posterettekanne) Huik, K; Soodla,P; Pauskar, M; Rajasaar, H; J\u00f5geda, E; Kallas, E; …<\/p>\n","protected":false},"author":128,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-7","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/pages\/7","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/users\/128"}],"replies":[{"embeddable":true,"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/comments?post=7"}],"version-history":[{"count":1,"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/pages\/7\/revisions"}],"predecessor-version":[{"id":197,"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/pages\/7\/revisions\/197"}],"wp:attachment":[{"href":"https:\/\/sisu.ut.ee\/hiv\/wp-json\/wp\/v2\/media?parent=7"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}